Short interest for Mineralys Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Mineralys Therapeutics's stock. Short interest data is updated every two weeks.

Mineralys Therapeutics Stock (NASDAQ:MLYS), Short Interest Report

Mineralys Therapeutics

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ACLS

APPS

ASTS

BETS

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BTDR

CAMP

CCTG

CVKD

DYNT

EVER

GPRO

HCTI

HKIT

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

LITE

LSPD

MGRX

MLGO

MLYS

MPWR

MRDB

NTGR

NVST

OSCR

PBAX

PYPL

QNST

ROMA

SYRA

TENX

THMO

TRUG

UCAR

VKTX

WETG

WIMI

YTEN

ZCMD

Shares of  Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

CYBR

MARA

WYNN

U.S. stocks traded mixed, with the Dow Jones gaining around 20 points on Thursday.

Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday

ALLO

ALTR

ALVR

ALXO

ANSS

APGE

ARBK

ASST

ATIF

ATRA

BROG

CETX

COMP

CYCC

DSKE

ENLV

FULC

GMBL

HUYA

IBRX

KRTX

LGCB

LITM

LTRY

MULN

NBTX

NCPL

NMRA

NTES

NXTP

PRME

PRTC

PRZO

RKLB

RMCO

SXTP

TRML

ZJYL

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics Inc

Macro Economic Events

Economics

Federal Reserve

Fed's Kashkari Says U.S. Has Long Term Housing Supply Challenge; Higher Rates Will Lead To Less Housing Supply In Short Term; Fed Has To Get Inflation Down

<p><strong>Sphere Entertainment Co</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPHR#NYSE">SPHR</a>) reported third-quarter FY24 sales growth of 98% year-on-year to $321.3 million,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/n38757302/sphere-entertainment-co-reports-fiscal-2024-third-quarter-results" rel="noreferrer noopener">missing the analyst consensus estimate of $324.63 million</a>.</p>
<p>For the third quarter, the Sphere segment reported revenues of&nbsp;$170.4 million, an increase of&nbsp;$169.7 million, as&nbsp;compared to the prior-year quarter.</p>
<p>MSG Networks segment reported total revenues of&nbsp;$151.0 million, down 6% from the prior year quarter.</p>
<p>Direct&nbsp;operating expenses increased to $154.040 million compared to $93.665 million last year. Selling, general&nbsp;and&nbsp;administrative expenses for the quarter were $123.149 million.</p>
<p>The operating loss for the quarter narrowed to $(40.4) million from $(101.9) million a year ago.</p>
<p>Adjusted operating income was $61.5 million versus an adjusted operating loss of&nbsp;$(18.7) million&nbsp;in the prior year quarter.</p>
<p>EPS loss of $(1.33)&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">missed the analyst</a>&nbsp;consensus estimate of $(0.12).</p>
<p>Sphere held $693.9 million in cash and equivalents as of March-end. Operating cash flow for nine months totaled $52.7 million.</p>
<p><strong>Price Action</strong>: SPHR shares traded lower by 5.10% at $39.08&nbsp;at last check&nbsp;Friday.</p>


Earnings

Equities

General

SPHR

Sphere Entertainment's Wild Ride: Q3 Sales Soar, Yet Fall Short Of Expectations

<p><a href="https://www.marijuanamoment.net/dea-appears-to-question-marijuanas-medical-value-despite-rescheduling-recommendation/">https://www.marijuanamoment.net/dea-appears-to-question-marijuanas-medical-value-despite-rescheduling-recommendation/</a></p>
<p>&nbsp;</p>


Cannabis

AKAN

CRON

GRWG

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

IMCC

LFLY

SNDL

TLRY

'DEA Appears To Question Marijuana's Medical Value Despite Rescheduling Recommendation' - Marijuana Moment

<p>Madison Square Garden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGE#NYSE">MSGE</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $11. This is a 85.71 percent decrease over earnings of $0.42 per share from the same period last year. The company reported $228.313 million in sales this quarter. This is a 13.46 percent increase over sales of $201.229 million the same period last year.</p>


MSGE

CORRECTION: Thursday, Madison Square Garden Reported Q3 GAAP EPS $0.06 Missed $0.11 Estimate, Sales $228.313M Beat $227.6M Estimate

Fed's Kashkari Says Current Baseline Is That Strong Productivity Rates Will Moderate

<p>BWS Financial  analyst Hamed Khorsand   maintains Arlo Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARLO#NYSE">ARLO</a>) with a Buy and maintains $17 price target.</p>


Price Target

Analyst Ratings

ARLO

BWS Financial Maintains Buy on Arlo Technologies, Maintains $17 Price Target

<p>Wedbush  analyst Scott Devitt   maintains Tripadvisor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRIP#NASDAQ">TRIP</a>) with a Neutral and lowers the price target from $30 to $21.</p>


TRIP

Wedbush Maintains Neutral on Tripadvisor, Lowers Price Target to $21

<p>Wedbush  analyst Taz Koujalgi   reiterates Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) with a Outperform and maintains $130 price target.</p>


Reiteration

OKTA

Wedbush Reiterates Outperform on Okta, Maintains $130 Price Target

<p>Roth MKM  analyst Matt Koranda   maintains FIGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) with a Buy and lowers the price target from $7.5 to $6.75.</p>


FIGS

Roth MKM Maintains Buy on FIGS, Lowers Price Target to $6.75

<p><strong>Digital Currency Group</strong> (DCG), the investment firm behind <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38728621/spot-bitcoin-etfs-clock-11m-net-inflows-on-wednesday-as-grayscale-shifts-focus-to-spot-eth">industry giant <strong>Grayscale</strong></a>, reported a strong first quarter with overall revenue climbing 11% to $229 million.</p>
<p><strong>What Happened</strong>: This positive performance comes despite ongoing challenges faced by Grayscale&#8217;s flagship product, the <strong>Grayscale Bitcoin Trust</strong> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#OTC">GBTC</a>), Coindesk <a href="https://www.coindesk.com/business/2024/05/09/grayscale-parent-digital-currency-group-reports-229m-revenue-for-q1/?utm_term=organic&amp;utm_campaign=coindesk_main&amp;utm_medium=social&amp;utm_source=twitter&amp;utm_content=editorial">reported</a>.</p>
<p>&#8220;The first quarter of 2024 was marked by several exciting developments for our industry,&#8221; DCG said in a letter to shareholders, highlighting the approval of the long-awaited Bitcoin ETF and the surge in Bitcoin prices. &#8220;Against this backdrop, we are pleased to showcase a strong start to the year for DCG.&#8221;</p>
<p><strong>Grayscale Holds Steady Despite Outflows</strong></p>
<p>Grayscale, a subsidiary of DCG, contributed $156 million to the company&#8217;s overall revenue. This figure remained relatively flat compared to the previous quarter, even amidst significant outflows from GBTC. </p>
<p>The conversion of GBTC into a spot ETF in January opened the door for competition with lower fees, leading some investors to move their holdings elsewhere.</p>
<p>&#8220;While Grayscale expected outflows alongside increased competition under the ETF wrapper, Q1 revenue attributable to GBTC nevertheless exceeded our expectations,&#8221; the company stated.</p>
<p><figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure></p>
<p><em>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38756389/bitcoin-spot-etfs-collect-11-29m-net-inflows-on-thursday">Bitcoin Spot ETFs Collect $11.29M Net Inflows On Thursday</a></em></p>
<p><strong><strong>The Future Of Grayscale</strong></strong></p>
<p>Other DCG subsidiaries, however, painted a brighter picture. The cryptocurrency mining pool Foundry and the global investment platform Luno reported impressive revenue increases of 35% and 46%, respectively.</p>
<p>The question remains: can Grayscale weather the storm? </p>
<p>The company acknowledged the need to adjust its fees but has yet to implement those changes. </p>
<p>To stay competitive, Grayscale has filed for a new Bitcoin ETF with a significantly lower fee structure, but its approval by the SEC is still pending.</p>
<p><strong>Looking Ahead: Benzinga&#8217;s Future Of Digital Assets Event</strong></p>
<p>The future of Grayscale and the broader digital asset industry will undoubtedly be a hot topic at upcoming industry events. </p>
<p>Benzinga&#8217;s  <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> conference, happening on Nov. 19, is one such platform where key players will gather to discuss the latest trends, regulations, and investment <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38739003/how-much-did-donald-trumps-crypto-portfolio-pump-after-he-said-hes-fine-with-it">opportunities in the crypto space.</a></p>
<p><em>Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38741679/joseph-lubin-accuses-sec-of-stifling-crypto-growth-amid-legal-showdown">Joseph Lubin Accuses SEC Of Stifling Crypto Growth Amid Legal Showdown</a></em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

GBTC

Digital Currency Group Sees Revenue Rise Despite Grayscale Struggles

<p>Financial giants have made a conspicuous bearish move on Shopify. Our analysis of options history for Shopify (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) revealed 8 unusual trades.</p>
<p>Delving into the details, we found 12% of traders were bullish, while 62% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $120,475, and 5 were calls, valued at $487,755.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $35.0 to $100.0 for Shopify during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for Shopify options trades today is 1431.71 with a total volume of 1,559.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Shopify's big money trades within a strike price range of $35.0 to $100.0 over the last 30 days.</p>
<h3>Shopify 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715351538_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.5</td>
<td>$7.35</td>
<td>$7.35</td>
<td>$100.00</td>
<td>$288.8K</td>
<td>878</td>
<td style="text-align: right;">107</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/20/24</td>
<td>$7.8</td>
<td>$7.7</td>
<td>$7.8</td>
<td>$60.00</td>
<td>$89.7K</td>
<td>970</td>
<td style="text-align: right;">839</td>
</tr>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$5.15</td>
<td>$5.05</td>
<td>$5.15</td>
<td>$65.00</td>
<td>$48.9K</td>
<td>4.4K</td>
<td style="text-align: right;">443</td>
</tr>
<tr>
<td>SHOP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$15.1</td>
<td>$14.25</td>
<td>$14.85</td>
<td>$65.00</td>
<td>$44.5K</td>
<td>1.2K</td>
<td style="text-align: right;">30</td>
</tr>
<tr>
<td>SHOP</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/20/24</td>
<td>$8.3</td>
<td>$8.0</td>
<td>$8.15</td>
<td>$60.00</td>
<td>$40.7K</td>
<td>970</td>
<td style="text-align: right;">124</td>
</tr>
</tbody>
</table>
</p>
<h3>About Shopify</h3>
<p>Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.</p>
<h3>Shopify's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 4,735,740, the SHOP's price is down by -1.2%, now at $61.7. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 82 days.</li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Shopify, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

SHOP

Looking At Shopify's Recent Unusual Options Activity

<p>Barrington Research  analyst Gary Prestopino   maintains Cantaloupe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTLP#NASDAQ">CTLP</a>) with a Outperform and maintains $10 price target.</p>


CTLP

Barrington Research Maintains Outperform on Cantaloupe, Maintains $10 Price Target

<p>Deep-pocketed investors have adopted a bullish approach towards Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CRM usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Salesforce. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 61% leaning bullish and 38% bearish. Among these notable options, 4 are puts, totaling $500,292, and 9 are calls, amounting to $413,815.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $180.0 to $300.0 for Salesforce over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Salesforce stands at 1083.22, with a total volume reaching 380.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Salesforce, situated within the strike price corridor from $180.0 to $300.0, throughout the last 30 days.</p>
<h3>Salesforce Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715351533_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$14.0</td>
<td>$13.8</td>
<td>$13.85</td>
<td>$250.00</td>
<td>$311.6K</td>
<td>2.2K</td>
<td style="text-align: right;">225</td>
</tr>
<tr>
<td>CRM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$6.7</td>
<td>$6.55</td>
<td>$6.6</td>
<td>$260.00</td>
<td>$105.6K</td>
<td>1.0K</td>
<td style="text-align: right;">14</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$100.9</td>
<td>$99.5</td>
<td>$100.0</td>
<td>$180.00</td>
<td>$100.0K</td>
<td>313</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/16/24</td>
<td>$37.45</td>
<td>$37.0</td>
<td>$37.0</td>
<td>$250.00</td>
<td>$74.0K</td>
<td>631</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>CRM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$56.75</td>
<td>$56.4</td>
<td>$56.75</td>
<td>$240.00</td>
<td>$68.1K</td>
<td>1.6K</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
</p>
<h3>About Salesforce</h3>
<p>Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.</p>
<p>Following our analysis of the options activities associated with Salesforce, we pivot to a closer look at the company's own performance.</p>
<h3>Salesforce's Current Market Status</h3>
<ul>
<li>With a volume of 499,407, the price of CRM is up 1.08% at $278.13. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 19 days.</li>
</ul>
<h3>What The Experts Say On Salesforce</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $353.4.</p>
<ul>
<li>An analyst from Wolfe Research downgraded its action to Outperform with a price target of $365. </li>
<li>An analyst from Jefferies persists with their Buy rating on Salesforce, maintaining a target price of $360. </li>
<li>Reflecting concerns, an analyst from JMP Securities lowers its rating to Market Outperform with a new price target of $342.</li>
<li>Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $350.</li>
<li>An analyst from RBC Capital downgraded its action to Outperform with a price target of $350. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Salesforce, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Unpacking the Latest Options Trading Trends in Salesforce

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Cava Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CAVA, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Cava Group.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 33% bullish and 44%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $228,395, and 4 are calls, for a total amount of $177,635.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $100.0 for Cava Group, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Cava Group's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Cava Group's significant trades, within a strike price range of $60.0 to $100.0, over the past month.</p>
<h3>Cava Group Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715351527_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th style="text-align: right;"><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$19.6</td>
<td>$18.6</td>
<td>$18.6</td>
<td>$100.00</td>
<td>$96.6K</td>
<td style="text-align: right;">76</td>
<td style="text-align: right;">1</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$4.1</td>
<td>$3.9</td>
<td>$4.1</td>
<td>$75.00</td>
<td>$81.9K</td>
<td style="text-align: right;">134</td>
<td style="text-align: right;">223</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$4.6</td>
<td>$4.5</td>
<td>$4.6</td>
<td>$75.00</td>
<td>$45.9K</td>
<td style="text-align: right;">134</td>
<td style="text-align: right;">324</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/21/24</td>
<td>$2.65</td>
<td>$2.5</td>
<td>$2.5</td>
<td>$70.00</td>
<td>$37.7K</td>
<td style="text-align: right;">301</td>
<td style="text-align: right;">40</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/10/24</td>
<td>$3.7</td>
<td>$3.5</td>
<td>$3.5</td>
<td>$75.00</td>
<td>$35.0K</td>
<td style="text-align: right;">371</td>
<td style="text-align: right;">94</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cava Group</h3>
<p>Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates the majority of its revenue from the CAVA segment.</p>
<p>Having examined the options trading patterns of Cava Group, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Cava Group's Current Market Status</h3>
<ul>
<li>With a trading volume of 895,538, the price of CAVA is up by 5.55%, reaching $79.56.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 18 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Cava Group</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $69.2.</p>
<ul>
<li>Maintaining their stance, an analyst from TD Cowen continues to hold a Buy rating for Cava Group, targeting a price of $73. </li>
<li>An analyst from Morgan Stanley persists with their Overweight rating on Cava Group, maintaining a target price of $68. </li>
<li>An analyst from Wedbush persists with their Outperform rating on Cava Group, maintaining a target price of $74. </li>
<li>In a cautious move, an analyst from Barclays downgraded its rating to Equal-Weight, setting a price target of $58. </li>
<li>Reflecting concerns, an analyst from TD Cowen lowers its rating to Buy with a new price target of $73.</li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Cava Group, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


CAVA

Looking At Cava Group's Recent Unusual Options Activity

<p>Wedbush  analyst Michael Pachter   reiterates Skillz (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKLZ#NYSE">SKLZ</a>) with a Outperform and maintains $15 price target.</p>


SKLZ

Wedbush Reiterates Outperform on Skillz, Maintains $15 Price Target

<p>Roth MKM  analyst Matt Koranda   maintains YETI Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) with a Neutral and lowers the price target from $43 to $42.</p>


YETI

Roth MKM Maintains Neutral on YETI Holdings, Lowers Price Target to $42

<p>Roth MKM  analyst Eric Handler   maintains Playtika Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTK#NASDAQ">PLTK</a>) with a Neutral and raises the price target from $8 to $9.</p>


PLTK

Roth MKM Maintains Neutral on Playtika Holding, Raises Price Target to $9

<p>In the United States, the definition of wealth can often seem skewed by the extravagant lifestyles of <a href="https://www.benzinga.com/real-estate/24/04/38498372/jeff-bezos-is-so-rich-that-spending-1-000-000-is-like-the-average-person-spending-1-here-is-how-he-s">billionaires like Jeff Bezos</a>. However, the reality of entering the top 1% of American wealth is far more attainable than the headlines might suggest.&nbsp;</p>
<p>According to the latest findings from the 18th edition of the Wealth Report by Douglas Elliman and Knight Frank, a person needs $5.8 million to be considered in the wealthiest 1% — a figure that, while substantial, is a far cry from the billionaire benchmark.</p>
<p><strong>Don't Miss:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/money/are-you-rich"><strong>Are you rich?</strong></a><strong> Here&#8217;s what Americans think you need to be considered wealthy.</strong></li>
<li><strong>Can you guess how many Americans successfully retire with $1,000,000 saved?</strong><a href="https://www.benzinga.com/money/red-ventures"><strong> </strong><strong>The percentage may shock you</strong></a><strong>.</strong></li>
</ul>
<p>This threshold of $5.8 million marks an increase from the previous $5.1 million, illustrating the relentless pace of inflation.&nbsp;</p>
<p>The U.S. ranks fourth globally in the wealth required to join this elite group, trailing behind Monaco, Luxembourg, and Switzerland. Monaco, known for its opulent lifestyle and tax benefits, tops the list with a required $12.9 million to enter its 1%.</p>
<p>Knight Frank&#8217;s report annually explores global wealth distribution, focusing on the investments and lifestyles of <a href="https://www.benzinga.com/personal-finance/24/05/38697769/can-you-guess-what-percentage-of-a-high-net-worth-individuals-portfolio-is-typically-held-in-ret">high-net-worth (HNW)</a> and ultra-high-net-worth (UHNW) individuals — defined as those with assets of at least $1 million and $30 million, respectively. The report draws on insights from hundreds of wealth advisers and banking professionals to offer a comprehensive view of the financial landscapes these wealthy individuals navigate.</p>
<p>The year 2022 saw a 10% decrease in the total wealth of the richest households and a 4% reduction in the global UHNW population. Despite a tumultuous year marked by rising interest rates and geopolitical instability, there is a silver lining. The latest data shows a recovery, with a 4.2% increase in the number of UHNW individuals worldwide, led by strong gains in the Middle East and the U.S., thanks to robust economic growth and rebounding equity markets.</p>
<hr class="wp-block-separator has-alpha-channel-opacity" />
<p><strong>Trending: If the United States had access to</strong><a href="https://www.benzinga.com/money/public-hys-avgamerican"><strong> </strong><strong>today&#8217;s high-yield savings accounts rates</strong></a><strong> in 2015, it wouldn&#8217;t need to save another penny.</strong></p>
<hr class="wp-block-separator has-alpha-channel-opacity" />
<p>The year 2022&#8217;s dip in wealthy individual numbers was an anomaly in an otherwise upward trend. This followed a record-setting 2021 where the ultrawealthy population surged by over 9%. Looking forward, the impending Great Wealth Transfer is poised to redefine the landscape of wealth in the U.S.&nbsp;</p>
<p>Over the next two decades, approximately $90 trillion in assets is expected to shift hands, ushering in a new era where affluent millennials could become the wealthiest generation in history.</p>
<p>Whether you&#8217;re on the path to <a href="https://www.benzinga.com/personal-finance/financial-advisors/24/01/36665585/how-much-money-do-you-need-to-make-to-be-among-the-top-1-5-or-10-based-on-inc">joining the top 1%</a> or just starting, it&#8217;s important to focus on what truly matters: achieving a sustainable and fulfilling lifestyle that aligns with your personal goals and values, not merely striving to meet societal benchmarks. Wealth is highly concentrated at the top; naturally, not everyone will be a part of this elite group, and that&#8217;s perfectly OK.</p>
<p><a href="https://www.benzinga.com/money/smartasset">Consulting a financial adviser</a> can help you tailor a financial strategy that suits your specific needs and aspirations. Achieving a fulfilling life is not contingent upon being in the top 1%. Wealth building is a long-term endeavor — a marathon, not a sprint. By maintaining smart financial habits and focusing on your financial health, you can lay the groundwork for a secure future.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong>82% of Americans aren&#8217;t using</strong><a href="https://www.benzinga.com/money/public-hys"><strong> </strong><strong>this government secured 5% passive income stream</strong></a><strong>, are you one of them?</strong></li>
<li><strong>Boomers and Gen Z agree they need a salary of around $125,000 a year to be happy,</strong><a href="https://www.benzinga.com/money/genz-salary-adv"><strong> </strong><strong>but millennials say they need how much?</strong></a></li>
</ul>


Personal Finance

How Much Do You Need To Join The Richest 1%? — It May Be Less Than You Realize

<p>Barrington Research  analyst Michael Petusky   maintains Haemonetics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAE#NYSE">HAE</a>) with a Outperform and raises the price target from $105 to $107.</p>


Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $107

Fed's Kashkari Says Strong U.S. Tech Sector Underpins Why U.S. Has World's Reserve Currency

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Resmed (RMD – Research Report), Mineralys Therapeuti...

Analysts Offer Insights on Healthcare Companies: Resmed (RMD), Mineralys Therapeutics, Inc. (MLYS) and Addus Homecare (ADUS)

QuidelOrtho stock falls 11% on Savanna PVP4+ assay update

Goldman starts Mineralys at buy, cites upcoming drug data

What To Buy After You Sell The Russell 2000

The latest update is out from Mineralys Therapeutics, Inc. (MLYS). Alexander Asam, Ph.D., has announced he will step down from the Board of Directo...

Mineralys Therapeutics Board Member Announces Departure

Even with a brief drop this week, the markets are showing strength this year, with the S&P 500 climbing 8%. However, there's a big question on inve...

Goldman Sachs Predicts Over 120% Rally for These 2 'Strong Buy' Stocks

Mineralys Therapeutics GAAP EPS of -$0.70 misses by $0.03

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mineralys Therapeutics, Inc. (MLYS – Research Report...

Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Anika Therapeutics (ANIK)

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p><strong>Mineralys Therapeutics</strong> (NASDAQ:<span><a href="https://investorplace.com/stock-quotes/mlys-stock-quote/"><strong>MLYS</strong></a></span>) just reported results for the first quarter of 2024.</p><ul><li>Mineralys Therapeutics reported earnings per share of -70 cents. This was below the analyst estimate for EPS of -67 cents.</li><li>The company did not report any revenue for the quarter.</li></ul><div><p>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/earning-results/2024/05/mlys-stock-earnings-mineralys-therapeutics-for-q1-of-2024/">MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024

In a report released yesterday, Mohit Bansal from Wells Fargo assigned a Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report), with ...

Mineralys Therapeutics: Strong Buy on Upcoming ADVANCE Trial Results and Robust Financial Health

ACRV

ADUS

ANIK

AVUV

OLMA

QDEL

SKWD

VTWO

Press Releases

Mineralys Therapeutics Further Defines Endotype-Specific, Targeted Approach to Treatment of Uncontrolled or Resistant Hypertension with Lorundrostat Data at AHA Scientific Sessions 2023

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Mineralys Therapeutics Stock (NASDAQ:MLYS), Short Interest Report

People Also Watch